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Summary.-Using the DMBA-induced mammary tumour as a model, the effect of
hormone manipulation on steroid sulphurylation and on oxidative and reductive
metabolism has been investigated. Oestradiol-17p, or oestradiol-17p + progesterone,
administered to oophorectomized animals, had no effect on adenosine-3'-phosphate-
5'-phosphosulphate formation in the tumours. Dehydroepiandrosterone sulphotrans-
ferase was also unaffected. A large increase in oestrogen sulphotransferase following
administration ofoestrogen+progesterone was observed in some but not all tumours,
and the overall results were not statistically significant. The major metabolities
of dehydroepiandrosterone, by both human and carcinogen-induced rat mammary
tumours in vitro, are 7-oxygenated derivatives. Oestrogen administration led to
a significantly decreased production of total 7-oxygenated derivatives of dehydro-
epiandrosterone. Conversion to 5-androstene-3p,17p-diol was unaffected by the
hormones. The rate of formation of oestradiol-17p from oestrone was increased 5-
fold in growing tumours from animals receiving oestrogen, or oestrogen+proges-
terone, compared to regressing tumours in oophorectomized control animals.
A HYPOTHESIS has been presented im-
plicating adrenal dehydroepiandrosterone
(DHEA) and DHEA sulphate (DHEAS)
in the aetiology of human breast cancer
(Adams, 1977). The main metabolites of
DHEA, produced by in vitro incubation
with human mammary tumours, are 7-
oxygenated derivatives (7a-hydroxy DH-
EA, 7P-hydroxy DHEA and 7-oxo DHEA)
and 5-androstene-3g,17/-diol (Li et al.,
1978). The latter can cause translocation
of the oestrogen receptor in both the
uterus and mammary tumours (Adams
et al., 1978; Nicholson et al., 1978).
Although it is difficult to be certain of the
exact role played by the 7-hydroxylation
system in mammary tissue, it has been
suggested (Adams et al., 1978) that it could
function as an inactivation step to modify
oestrogen receptor translocation by 33-
hydroxy-A5-androstenes, which are known
to occur in relatively high concentrations
in human mammary tumours (Maynard
et al., 1977). Thus high levels of DHEAS
in the blood could lead to highintracellular
levels ofDHEA and its metabolites formed
in situ in mammary tissue.
Pathways of DHEA metabolism similar
to those established in human mammary
tumours also occur in 7,12-dimethylbenz-
(a)anthracene (DMBA)-induced rat mam-
mary tumours (Li et al., 1976). It was
thus of interest to use this as a model to
study the influence of an altered sex-
hormone milieu in tumour-bearing rats
upon subsequent DHEA metabolism in the
tumour. In parallel studies, the influence
of an altered hormone milieu on oestrogen
metabolism by these tumours has been
investigated.
One other aspect of DHEA metabolism
by human mammary tumours, i.e. forma-
tion of the sulphate ester, is of relevance
when considered together with the sul-
phurylation of oestradiol-17/. Measure-
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in vitro has been shown to relate to the
patient's subsequent prognosis (Dao &
Libby, 1972). Since the enzymes respon-
sible for the sulphurylation of DHEA and
oestradiol-17,f are also present in DMBA-
induced rat mammary tumours, the in-
fluence of similar hormone manipulations
on steroid sulphurylation in the tumours
has been included in the present, investiga-
tionl.
MATERIALS AND METHODS
Radioactive materials. [35S] sulphate (car-
rier free), 114C] dehydroepiandrosterone
(52 mCi/mmol) and [4-14C] oestrone (50
mCi/mmol) were purchased from the Radio-
chemical Centre, Amersham. U.K. [35S]
adenosine -3' -phosphate-5' -phosphosulphate
([35] PAPS) and unlabelled PAPS wvere pre-
pared as described previously (Adams et al.,
1974).
DMBA-induedtumnour8. FemaleSprague-
Dawrley rats (50 days old) wvere given a
single oral dose of 20 mg DMBA in peanut
oil. Animals wsere provided with rat chow,
and water ad libitum and held in an
animal house subjected to the normal day-
light cycle. When turnours had reached an
approximate size of 2 x 2 cm, oophorectomy
was performed. Tumours which regressed
after oophorectomy, as judged by measure-
ment writh calipers daily for 10 days, wNere
classed as hormone-dependent and provided
the basis for this study. These rats wvere then
divided into 3 groups: Group 1 did not
receive any further treatment and acted as
controls, Group 2 received daily s.c. injec-
tions of oestradiol-17f in normal saline (1.5
/.g/day) until regrowth of the tumour oc-
curred. while Group 3 received oestradiol-
17fl as in Group 2, but on the last 5 days
before killing progesterone (2.5 mg) in propy-
lene glycol wvas also injected s.c. (in this case
regrowth for 20 days wNas allowed before
progesterone was administered). All animals
were killed at about the same time in the
morning. Six tumours wrere subjected to the
biochemical studies in each of the 3 groups,
and sample sections were retained for his-
tology.
PAPSsynthesis.-Tumour tissue (0 5 g) wa.s
cut into small pieces and packed into the
chamber of a stainless-steel cylinder block
pre-chilled in dry ice and pounded with a
close-fitting stainless-steel plunger. The
resulting powder was then homogenized in
2 5 ml of 04154M KCI containing 0ImM
dithiothreitol, using a Potter-Elvejhem homo-
genizer with Teflon head.
After centrifugation for 10 min at 6,000 g
to remove cell debris, the supernatant was
spun at 100.000 g for 1 h. An incubation
mixture was set up which contained, in a total
volume of 2 0 ml: 1 82 jumol ATP, 3 64 Ftmol
MgCl2, 0 04 1.mol [35S] Na2SO4 (sp. act.
1500 d/min/pmol), 9 1imol Tris-HCl buffer
(pH 7.4) and 0.1 ml of cytosol. Reaction was
carried out for 30 min at 37°C and stopped by
placing the tubes in a boiling water bath for
1 min. After centrifugation to remove any
precipitated protein, a sample (10 ,tl) was
applied as a 2cm streak to strips ofWhatman
No. 1 paper. Electrophoresis was carried out
for 4 h in 0-05M sodium phosphate buffer,
pH 6-0. A potential of 10 V/cm was applied
and the procedure carried out in the cold
room. Radioactive [35S] PAPS and [35S]
adenosine-5'-phosphosulphate (APS) on
paper electrophoretograms were detected by
scanning with a Nuclear Chicago Actigraph
III instrument, and identified by comparison
with the relative mobilities of authentic
compounds. The radioactive regions were cut
out for liquid-scintillation counting. Activity
of the PAPS-synthesizing system was then
expressed as pmol/mg cytosol protein used in
the incubation.
Oestrogen and steroid alcohol sulphotrans-
ferases. Sulphotransferase assays in tumours
used preformed [35S] PAPS, and were carried
out in incubation mixtures of the following
composition: 0(02 [kmol [35S] PAPS (2 x 105
d/min), 3 p.mol MgC12, 8 Hmol Tris-HCl (pH
7.4), 7-5 nmol steroid in 5 ,ul of propylene
glycol, and 0 1 ml ofcytosol in a total volume
of 0-15 ml. Incubation was continued for 1 h
at 37°C. Controls contained propylene glycol
alone. Steroid [35S] sulphate was assayed by
extraction into ethyl acetate (Dao & Libby,
1972). Counts in the controls were sub-
tracted. and the net counts expressed as
pmol of steroid sulphate/mg protein/h.
DHEA metabolism.-Incubation of finely
minced tumour tissue (0 5 g) in 2 ml of modi-
fied Krebs-Ringer phosphate buffer (pH 7.4)
wN-ith [4-14C] dehydroepiandrosterone (0 5
,uCi) and an NADPH-generating system was
carried out as described by Li et al. (1978).
Products were extracted, separated, deter-
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mined and characterized as described in pre-
vious publications (Li et al., 1976, 1978).
Oestrone metabolism.-Minced tumour tis-
sue (0-5 g) was added to 5 ml Krebs-Ringer
phosphate buffer (pH 7.4) fortified with
16 7mM glucose, 50mM sodium fumarate and
10mM nicotinamide. [4-14C] oestrone (015
,tCi) in 0 05 ml ethanol was added and the
mixture incubated at 37TC for 2 h with shak-
ing in air. After addition of carriers (10 jug
each ofoestrone, oestradiol-17P and oestriol),
the reaction was stopped by addition of5 vol-
umes of acetone. The mixture was homogen-
ized and filtered and the residue washed with
acetone. After removal of the acetone, the
remaining aqueous phase was extracted with
ether (3 x 15 ml) and, after drying (Na2SO4),
the products were separated by thin-layer
chromatography on silica gel using chloro-
form ethyl acetate (9:1, v/v). The [4-14C]
oestradiol peak, revealed after scanning, was
cut out and measured by liquid-scintillation
counting. The identity of the oestradiol was
confirmed by derivative formation and com-
parison with authentic compounds in various
thin-layer chromatography systems.
Statistical evaluation.-Student's two-sided
t test was applied. Tabulated results are ex-
pressed as means + s.e.
Liquid-scintillation counting.-This was car-
ried out using a Triton-toluene phosphor
system as described by Li et al. (1978). A
computerized Packard 2650 instrument was
used and quench corrections applied by the
external standard inethod.
RESULTS
Sulphurylation studies
Formation of APS from ATP and
[35S] S042- reached a maximum after 20
5
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Fia. 35S-Nucleotide synthesis from ATP
and [35S] S042-, using the cytosol fraction
from a DMBA-induced rat mammary
tumour.
min and then the concentration remained
static. This is shown in the Figure and
was typical of the data obtained with 4
separate tumours. In Table I, values
listed under "PAPS" represent the sum of
PAPS+APS, or the "PAPS potential"
assayed after 30 min. Oestrogen alone, or
oestrogen followed by progesterone, had
no significant influence, either on PAPS
potential or on the actual PAPS values
(not shown).
DHEA sulphotransferase activity was
unaltered by hormone administration. In
contrast, oestrogen alone, or more es-
pecially oestrogen +progesterone, led to an
increase in the mean oestrogen sulpho-
transferase activity, which was 4-fold
TABLE J.-35S-sulphate activation and steroid sulphurylation in mammary tumours
Group
of
rats
1 Oop:
"PAPS"*
(pmol/
30 min/mg
Treatment protein)
ihorectomized 358 + 69
2 Oophorectomized
+oestradiol-17f
3 Oophorectomized
+oestradiol-17P
+progesterone
E2St DHEASt
(pmol/h/mg protein)
18+10 43+4
446+68 30+7 39+4_
362+57 78+30 32+ 15
* PAPS synthesis measured as the sum of PAPS+adenosine-5'-phosphosulphate (APS). See Fig. 1.
t E2S= 17f,-oestradiol-3-sulphate; DHEAS=DHEA-3-sulphate. Preformed [35S]PAPS at saturating
evels was used as substrate.
Values are means + s.e.
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TABLE lI.-Metabolism of DHEA and oestrone by mammary tumours
% Conversion of [4-14C] DHEA to
Total
7a-hydroxy 7fl-hydroxy 7-oxygenate(d 5-a
Group* DHEA DHEA 7-oxo-DHEA DHEA 3,
1 9-52 + 1-19 3-02 + 0-28 2-69 + 0 39 15-3 +1-63 5
2 6-91+1-25 2-29 + 0-20 0-40+0-31t 9-64+0-31tt 5
3 6-51+1-14 3-17+0-37 1-92+0-53 11-6+1-23ttt 6
* See Table I.
t Group 2 vs Group 1, P < 0 001.
tt Group 2 vs Group 1, P< 0-02.
ttt Group 3 vs Group 1, P<0 1 (NS). Group 3 vs Group 2, P>0-25 (NS).
Separate groups of animals used in experiments with [4- 14C] oestrone.
Group 2 vs Group 1, P < 0 005.
*** Group 3 vs Group 1, P<0-00l.
Values are means + s.e.
when progesterone was included. However,
owing to the variability between tumours,
these results were not significant (Group 3
vs Group 1, P < 0 1, Table I). Tumours
from oophorectomized animals (Group 1)
generally showed degenerative regressional
changes on histological examination.
These changes occurred mostly in the form
of pools of mucinous material deposited
in the lobular units. In some tumours, the
lobular units had lost their distinct archi-
tectural form and showed diffuse infiltra-
tion of the connective tissue. Tumours
from animals receiving oestrogen (Group
2) were generally more cellular, the
mucinous material had largely disappeared
and infiltration of the connective tissue
was common. Oestrogen +progesterone
(Group 3) led to tumours with a higher
degree of structural organization and an
increased secretion of PAS+ material. The
stroma of tumours from Groups I and 2
showed considerable variegation, and in
some cases diffuse inflammatory response
with the presence of mast cells.
Metabolism of [4-14C] DHEA and
[4-14C] oestrone
Major products of the in vitro metab-
olism of DHEA by rat mammary tumours
were previously shown to be 7ac- and 73-
hydroxy DHEA, 7-oxo DHEA and 5-
androstene-3/,17/3-diol (Li et al., 1976).
Oestrogen administration to oophorecto-
mized rats led to a drop in each of the
7-oxygenated products of DHEA. Al-
though the total 7-oxygenated products
0° Conversion of
A-[4-14C] oestrone to
sndrostene-
6,17f-diol
i-77+0-86
i-29+0-87
)-81 +0-86
oestradiol-17f,
4-83 + 1-27
23-6 + 4-39**
26-9 + 0 97***
were significantly reduced by some 37%
(P < 0 02) by oestrogen administration,
reduced formation ofthe main component,
7a-hydroxy DHEA, was not significant
(P<0 2). Progesterone tended to reverse
the effects of oestrogen, as judged by
formation of total 7-oxygenated products
(Table II). Formation of 5-androstene-
3/,17/3-diol was unaltered by hormone
administration. Incubation of [4-14C]
oestrone (3 nmol) with 05g samples of
tumour minces in Krebs-Ringer buffer
fortified with glucose and nicotinamide,
caused a 458% conversion to oestradiol-
17/. Treatment of oophorectomized ani-
mals with oestrogen, or oestrogen +pro-
gesterone, caused a 5-fold increase in the
rate of oestradiol formation from [4-14C]
oestrone (Table II).
DISCUSSION
Levels of steroid sulphotransferases in
human mammary tumours have been
shown to relate to the overall prognosis of
the patient, and to the response to hor-
mone ablation (Dao & Libby, 1972). The
ability ofan individual tumour to generate
sufficiently high concentrations of PAPS
plays a dominant role in the determination
of the degree of sulphurylation of steroids
added to the incubations of the tumour
extracts (Dao & Libby, 1972; Li et al.,
1976; Adams & Chandra, 1977). From
data of the type presented in the Figure,
it was calculated that the concentration
of PAPS in the incubations with DMBA-
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tumour cytosol preparations would only
reach 1-2 tM. The Km for PAPS, using
purified bovine placental oestrogen sulpho-
transferase, is 37 pM (Adams et al., 1974)
and the corresponding values and DHEA
sulphotransferase are 13 /M for enzyme
from rat liver and 20 /tM for enzyme from
bovine liver (Adams & McDonald, unpub-
lished). Thus, assay of oestrogen and 3/-
hydroxysteroid sulphotransferases were
carried out by addition of saturating con-
centrations of the cosubstrate PAPS. The
specific increase in oestrogen sulphotrans-
ferase by progesterone (Table I), although
not significant in the present experiments,
is comparable to a similar influence of this
hormone on the enzyme in the endomet-
rium in the gilt (Pack & Brooks, 1974)
and human (Buirchell & Hahnel, 1975)
uterus. In these cases, the enzyme is
induced by progesterone at the end of the
proliferative phase of the oestrous and
menstrual cycles, and appears to regulate
the localized concentration ofoestrogen by
conversion to the water-soluble inactive
conjugate. In the DMBA tumour proges-
terone may play a similar role, and would
provide another example of a "modifying"
effect of progesterone on oestrogen action.
Although progesterone administration led
to large increases in the activity of oestro-
gen sulphotransferase in some tumours,
the effect was not consistent, and the
results were not statistically significant.
The reason for this is unknown. No ap-
parent differences were noted on histo-
logical examination oftumoursections, and
rates of tumour regression after oophorec-
tomy were similar, and did not explain the
variance in oestrogen sulphotransferase
levels.
In mammary tumours from the rat
(Li et al., 1976) and human (Couch et al.,
1975; Li et al., 1978) 7-oxygenated pro-
ducts are the main metabolites formed
from IDHEA in vitro. It has been estab-
lished that these conversions are catalysed
by enzymes, and are not due to chemical
oxidation at the active methylene group
at position 7 in 5-androstenes (Li et al.,
1976). In an extensive series of experi-
9
ments, no evidence was found that 7-
hydroxy DHEA synthesis represented an
intermediate in a more elaborate bio-
synthetic pathway (Li & Adams, unpub-
lished). However, the presence of the 7-
hydroxyl group in 3/-hydroxy-A5-steroids
does convey certain properties which sug-
gest that the 7-hydroxylase may play an
important role in the cell. For example,
introduction of the 7-hydroxyl group into
5-androstene-33,17/-diol markedly re-
duced this steroid's capacity to combine
with the oestrogen receptor (Li et al.,
1978). In addition, the ability of DHEA
and 5-androstene-3/,17P-diol to inhibit
oestrogen sulphotransferase was nullified
by 7-hydroxylation (Adams et al., 1978).
Although oestrogen administration did
significantly lower formation of 7-oxygen-
ated derivatives of DHEA, the effect was
not pronounced. In rat liver, the 7-
hydroxylase for DHEA has unusual prop-
erties compared to other steroid hydroxy-
lases. It appears to fall more in the class
of a "constitutive" enzyme, since it is
present in the liver of sexually immature
males and females and, in contrast to
16oz-hydroxylase, the presence ofandrogen
at a critical period of neonatal life is not
needed for expression ofthe enzyme in the
liver (Tabei & Heinrichs, 1974). Both
7ac- and 16oz-hydroxylases for DHEA in
adult male rat liver are sensitive to light/
dark modulations, and it has been sug-
gested that the 7cx-hydroxylase is adrenal-
dependent, rather than both gonad- and
adrenal-dependent, as is the case of the
16a-hydroxylase (Schafer & Colas, 1975).
The 17/-hydrogenation of DHEA to
5-androstene-3p,173-diol was unaffected
by hormone administration (Table II)
which appears to reflect the situation in
rat liver; this transformation being un-
affected by castration in either sex (Tabei
& Heinrichs, 1974).
Mammary tumours whose growth was
stimulated by oestrogen, or oestrogen+
progesterone, showed a greater capacity
to convert oestrone to oestradiol-17/ than
regressing tumours (Table II). In vitro
studies have shown that human mammary
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tumours cultured in the presence of either
labelled oestrone or oestradiol-173 showed
higher ratios of oestradiol-17,B to oestrone
than did normal or benign tissues (Willcox
& Thomas, 1972; Geier et al., 1975). The
specific activities of oestradiol-178 de-
hydrogenase in subcellular fractions of
breast-cancer tissues are lower than those
from non-malignant tissue (Pollow et al.,
1977). Thus, whilst adecrease inoestradiol-
17/ dehydrogenase could explain the
decrease in oestradiol-17/ metabolism in
neoplastic mammary tissue, it is incon-
sistent with the observed higher con-
versions of oestrone to oestradiol-17,.
King et al. (1965) made the interesting
observation that faster-growing DMBA-
induced rat mammary tumours converted
oestrone to oestradiol at a greater rate
than slower-growing tumours. One ex-
planation for the in vitro results obtained
with DMBA-induced tumours (Table II)
and the human tumours referred to above,
could be an altered redox state of pyrimi-
dinenucleotides. There is well-documented
evidence that oestradiol-17, induces glu-
cose-6-phosphate dehydrogenase (GPDH)
in both normal and neoplastic mammary
tissue (Hilf et al., 1967; Ringler & Hilf,
1975). Furthermore, GPDH activity is
higher in neoplastic tissue (Smith et al.,
1966; Knox, 1967; Richards & Hilf, 1972)
and neoplastic mammary tissue contains
higher oestrogen-receptor concentrations
than normal mammary tissue, thus sug-
gesting a correlation between GPDH and
oestrogen receptor (Daehnfeldt & Schulein,
1975). An increase in NADPH/NADP+,
via raised GPDH levels, could then
account for the increase in the rate of
oestradiol-17, formation from oestrone
in DMBA-induced tumours after oestro-
gen administration to oophorectomized
animals.
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